ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P 500
5,976.97
-1.13%
US Tech 100
21,079.20
-1.25%
Dow Jones
42,197.79
-1.79%
Brent Oil
73.815
0.00%
Bitcoin
105,516.95
0.05%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Viridian Therapeutics Inc (VRDN) Quote

Viridian Therapeutics Inc

Viridian Therapeutics Inc (VRDN)

Viridian Metals Inc
Viridian Metals Inc
15.88
0.21
(1.34%)
Closed June 14 4:00PM
15 min delayed - Upgrade to Realtime
15.93
0.05
(0.31%)
After Hours: 7:57PM
15 min delayed - Upgrade to Realtime

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
15.93
Bid
15.21
Ask
16.50
Volume
708,745
15.18 Day's Range 15.93
9.90 52 Week Range 27.20
Market Cap
1.3B
Previous Close
15.67
Open
15.22
Last Trade
220
@
15.93
(formt)
Last Trade Time
Financial Volume
$ 11,127,355
VWAP
15.7001
Average Volume (3m)
892,784
Shares Outstanding
81,592,026
Dividend Yield
-
PE Ratio
-4.80
Earnings Per Share (EPS)
-3.31
Revenue
302k
Net Profit
-269.95M

About Viridian Therapeutics Inc

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being de... Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease. Show more

Sector
Medical Laboratories
Industry
Medical Laboratories
Website
www.viridiantherapeutics.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Viridian Therapeutics Inc is listed in the Medical Laboratories sector of the NASDAQ with ticker VRDN. The last closing price for Viridian Therapeutics was $15.67. Over the last year, Viridian Therapeutics shares have traded in a share price range of $ 9.90 to $ 27.20.

Viridian Therapeutics currently has 81,592,026 shares outstanding. The market capitalization of Viridian Therapeutics is $1.28 billion. Viridian Therapeutics has a price to earnings ratio (PE ratio) of -4.80.

Ask ADVFN Intelligence (AI)

VRDN Latest News

More News

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
May 06 2025
VRDN (1.34%)

Form 8-K - Current report
Edgar (US Regulatory)
May 06 2025
VRDN (1.34%)

Form ARS - Annual Report to Security Holders
Edgar (US Regulatory)
April 25 2025
VRDN (1.34%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.369.3342484557314.5716.2914.3675790015.52834051CS
43.326.128266033312.6316.2912.4877138514.23576319CS
120.785.1485148514915.1516.299.989278413.29629638CS
26-1.9-10.656197420117.8323.659.9107398616.36380074CS
523.3126.228209191812.6227.29.9116600317.66953311CS
1565.451.282051282110.53399.8488286319.28918264CS
260-5.46-25.525946704121.39399.4763912419.06883861CS

VRDN - Frequently Asked Questions (FAQ)

What is the current Viridian Therapeutics share price?
The current share price of Viridian Therapeutics is $ 15.93
How many Viridian Therapeutics shares are in issue?
Viridian Therapeutics has 81,592,026 shares in issue
What is the market cap of Viridian Therapeutics?
The market capitalisation of Viridian Therapeutics is USD 1.28B
What is the 1 year trading range for Viridian Therapeutics share price?
Viridian Therapeutics has traded in the range of $ 9.90 to $ 27.20 during the past year
What is the PE ratio of Viridian Therapeutics?
The price to earnings ratio of Viridian Therapeutics is -4.8
What is the cash to sales ratio of Viridian Therapeutics?
The cash to sales ratio of Viridian Therapeutics is 4.29k
What is the reporting currency for Viridian Therapeutics?
Viridian Therapeutics reports financial results in USD
What is the latest annual turnover for Viridian Therapeutics?
The latest annual turnover of Viridian Therapeutics is USD 302k
What is the latest annual profit for Viridian Therapeutics?
The latest annual profit of Viridian Therapeutics is USD -269.95M
What is the registered address of Viridian Therapeutics?
The registered address for Viridian Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Viridian Therapeutics website address?
The website address for Viridian Therapeutics is www.viridiantherapeutics.com
Which industry sector does Viridian Therapeutics operate in?
Viridian Therapeutics operates in the MEDICAL LABORATORIES sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RBNERobin Energy Ltd
$ 13.85
(313.43%)
101.81M
OPOceanPal Inc
$ 1.63
(125.45%)
80.28M
LGHLWLion Group Holding Ltd
$ 0.0052
(116.67%)
6.87M
NEONNeonode Inc
$ 16.83
(68.47%)
4.78M
ICONIcon Energy Corporation
$ 2.90
(62.01%)
59.04M
SBETSharpLink Gaming Inc
$ 9.2275
(-71.63%)
41.92M
AIHSSenmiao Technology Ltd
$ 0.381
(-63.01%)
16.8M
CHSNChanson International Holding
$ 0.22
(-60.00%)
15.15M
KWMK Wave Media Ltd
$ 2.91
(-50.43%)
2.59M
JZXNJiuzi Holdings Inc
$ 1.56
(-46.39%)
2.24M
HCTIHealthcare Triangle Inc
$ 0.0201
(-33.00%)
856.89M
GNLNGreenlane Holdings Inc
$ 0.0101
(-34.42%)
792.34M
CGBSCrown LNG Holdings Ltd
$ 0.1104
(31.43%)
788.42M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 12.655
(3.81%)
246.13M
NVDANVIDIA Corporation
$ 141.97
(-2.09%)
180.81M

VRDN Discussion

View Posts
Monksdream Monksdream 9 months ago
VRDN more upside possible

👍️0
it_happens it_happens 9 months ago
Touched 20s today. Maybe it will stay above 20 tomorrow
👍️0
power11 power11 9 months ago
LOW 20'S BY WEEKEND IMO !!!
GOOD LUCK
👍️0
it_happens it_happens 9 months ago
Good news. I don't think that this is merely a one-day runner.
👍️0
power11 power11 9 months ago
BTIG RESEARCH ADJUST PRICE TARGET TO 56 FROM 46; STRONG BUY !!
👍️0
it_happens it_happens 9 months ago
Over 15 and having a good day today
👍️0
Monksdream Monksdream 9 months ago
VRDN under $15
👍️0
Apprentice Apprentice 4 years ago
I put into it a lot of $
423 shares!
👍️0
Apprentice Apprentice 4 years ago
It just doesn't want to move above $18
Yet, it's not diving much either.
What do you think at this point? Sell temporarily and by later low?
My average is too high @17.76 !
👍️0
crudeoil24 crudeoil24 4 years ago
Viridian Therapeutics, Inc., formerly Miragen Therapeutics, Inc., is a biotechnology company. The Company is engaged in developing multiple product candidates to treat patients who suffer from thyroid eye disease (TED), a debilitating orphan disease, and has early-stage programs focused on other targets and indications. Its lead candidate, VRDN-001, is a clinical-stage anti-IGF-1R monoclonal antibody (mAb) that is under development for thyroid eye disease (TED). The Company's TED pipeline also includes VRDN-002 and VRDN-003. Its other programs include VRDN-004, which is under development for undisclosed rare orphan disease, and VRDN-005, which is under development for tick-borne disease (TBD). The Company also out licenses its programs.
👍️0

Your Recent History

NASDAQ
VRDN
Viridian Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN Ltd - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads